Emily Schepers

Papers

Total Citations

H-Index

About

Emily Schepers is a leading surgical oncologist whose research focuses on the management of adrenocortical carcinoma (ACC) and the optimization of minimally invasive surgical techniques. Her most-cited work, a 2022 nationwide analysis, directly challenges prevailing guidelines by evaluating the safety and efficacy of minimally invasive surgery (MIS) for resectable ACC. This study, with 10 citations, provides critical evidence that, in carefully selected patients, MIS may not compromise oncologic outcomes, offering a potential shift in clinical practice for this rare and aggressive cancer. Schepers’ contributions are pivotal in balancing surgical innovation with oncologic rigor, helping to refine treatment paradigms for complex endocrine tumors. Her work has been instrumental in advancing the conversation around surgical quality and patient selection, earning her recognition as a key voice in endocrine surgery. Through her research, Schepers continues to shape the future of surgical oncology, providing data-driven insights that empower surgeons to make more informed decisions for their patients.